Investlytic Investlytic
Log in Free Account
English
🕒 Last update: loading…09/11/2026

Stock Astera Labs, Inc. Common Stock ALAB

Astera Labs, Inc. Common Stock — Investlytic score 2/5 on the five criteria.

-
-
40/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 2/5 criteria met. Data as of 01/11/2026.

  • ✅ Price trend passed
  • ⚠️ Mixed growth
  • ✅ Debt passed
  • ❌ P/E failed
  • ❌ Correction failed

Price trend

Overall trend (8 years): the price has been multiplied by at least 1.5.

Price change 2024 → 2025: 25.60%

Price change 2025 → 2026: 55.51%

Price change 2026 (year to date): 44.07%

Financial growth

Revenue CAGR (4 years): 120.18%

Earnings CAGR (4 years): N/A

Growth status: positive trend (>1%/yr) in revenue, earnings data insufficient/N/A.

Debt

Debt-to-equity ratio: 0.03

Debt/equity < 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 104.31

P/E > 25.0 (maximum threshold).

Correction (6 months)

Current correction: 46.44% from the high over 6 months.

Excessive correction (> 20.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

Create a free account Log in
02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Astera Labs, Inc. Common Stock104.30.03+120.2 %🔒
Block, Inc.23.70.40+44.4 %–
Workday, Inc.20.50.37+44.9 %–
Atlassian Corporation38.40.92+33.9 %–
Coherent, Inc.43.30.48+20.8 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

Create a free account Log in
04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

Create a free account Log in
05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

Create a free account Log in
06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

Create a free account Log in
+

Key reported figures

Revenue, net income and net margin reported by Astera Labs, Inc. Common Stock over the latest fiscal years.

Revenue
853 m USD
fiscal year 2025
Net income
219 m USD
fiscal year 2025
Net margin
25.7 %
fiscal year 2025
Market cap
33.1 bn USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
202279.9 m-58.3 m-73.0 %n/a
2023116 m-26.3 m-22.7 %+45.0 %
2024396 m-83.4 m-21.1 %+242.2 %
2025853 m219 m25.7 %+115.1 %

Amounts converted to USD. Source: published annual accounts, collected on 06/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Astera Labs, Inc. Common Stock over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
solid accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
68.43
safe zone (above 2.99)
Piotroski Score
5 / 9
4 to 6: average accounts
Net Debt / EBITDA
-0.47 x
net cash
Fiscal year2022202320242025
Cash and investments163 m149 m914 m1.2 bn
Total Debt1.6 m2.9 m1.3 m35.1 m
Net Debt-74.5 m-42.2 m-78.3 m-132 m
Equity-85.3 m157 m965 m1.4 bn
Total assets212 m196 m1.1 bn1.5 bn
Operating cash flow-35.9 m-12.7 m137 m319 m
Investments (capex)3.9 m2.8 m34.2 m37.5 m
Free cash-flow-39.8 m-15.5 m102 m282 m
Share buybacks313,000210,0001.1 m0
Dividends paid0000

Amounts in USD, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)71.16 x
Price / book value16.61 x
Return on Equity (ROE)28.0 %
Return on Invested Capital (ROIC)19.3 %
Net margin29.6 %
Debt / equity0.00 x
Current ratio8.03 x
Free cash-flow yield1.0 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 09/11/2026.

+

Valuation and competitors

Astera Labs, Inc. Common Stock compared with its sector on the same exchange and with its main competitors.

Company P/E
76.9
101.1 % above the sector
Sector median P/E
38.2
technology, Nasdaq
Sector over 10 years
43.0
10-year median, range 30.8 to 59.5

Direct competitors

CompanyMarket cap (USD)P/ENet margin
Astera Labs, Inc. Common Stock44.9 bn104.325.7 %
Credo Technology Group Holding Ltd CRDO28.4 bn44.111.9 %
MaxLinear, Inc. MXL6.1 bn118.4-29.2 %
Marvell Technology, Inc. MRVL172 bn59.5-15.3 %
Texas Instruments Incorporated TXN275 bn39.028.3 %
Analog Devices, Inc. ADI202 bn42.320.6 %
TE Connectivity Ltd. TEL61.7 bn19.710.8 %
Sector median (Nasdaq)38.2

Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on . Competitors: comparable companies named by the data provider.

+

Analyst consensus and forecasts

What the financial analysts covering Astera Labs, Inc. Common Stock publish: ratings, price targets and earnings forecasts.

Majority rating
buy
18 analysts
Average price target
390.18 USD
from 275.00 USD to 500.00 USD, 31 targets over 12 months
Gap with the share price
+50.8 %
price 258.70 USD on 30/10/2026

Breakdown of ratings

strong buy 0buy 13hold 5sell 0strong sell 0

Average target over the last 3 months: 419.29 USD (7 targets).

Analyst forecasts

Fiscal yearRevenueNet incomeExpected EPS (range)P/E on this EPSAnalysts
20261.9 bn721 m3.99 (3.92 / 4.11)64.814
20273.1 bn1.2 bn6.49 (6.09 / 7.32)39.915
20284.0 bn1.5 bn8.24 (6.06 / 11.04)31.412

Amounts in USD, the reporting currency.

Track record against expectations: reported EPS above consensus 10 times over the last 10 releases.

Rating changes (12 months)

DateFirmBeforeAfter
19/10/2026TD CowenHoldHold
17/08/2026Northland Capital MarketsMarket PerformOutperform
05/08/2026JefferiesBuyBuy
05/08/2026Evercore ISI GroupOutperformOutperform
05/08/2026NeedhamBuyBuy

Source: ratings and forecasts published by analysts, collected on 07/11/2026. An analyst rating or target is not a guarantee.

+

Dividends and earnings

Astera Labs, Inc. Common Stock: dividend history, last distributions, stock splits and earnings releases.

No known dividend for this company.

Earnings releases

DatePublished EPSExpected EPSSurprise
04/08/20260.800.69+15.8 %
05/05/20260.610.54+13.6 %
10/02/20260.580.52+12.4 %
04/11/20250.490.39+25.7 %
05/08/20250.440.32+35.8 %
06/05/20250.330.28+16.2 %

Factual data: ex-dividend history and earnings calendar, as of 05/11/2026. A past dividend does not guarantee the next one.

+

Who owns the stock

Free float, institutional investors, large funds, executives and elected officials: declared positions in Astera Labs, Inc. Common Stock.

Free float
82.3 %
share of freely traded shares
Large funds tracked
28
hold the stock as of 2026Q2
Executives (insiders)
0 / 84
0 purchases, 84 sales in 130 days

Indices: Nasdaq 100 (since 22/06/2026).

Large funds tracked

FundSharesValue (USD)Weight in the fundChangeQuarter
Fidelity24.8 m12.0 bn0.5 %-2.7 %2026Q2
BlackRock13.7 m6.6 bn0.1 %+19.5 %2026Q2
State Street7.4 m3.6 bn0.1 %+120.7 %2026Q2
Invesco4.9 m2.4 bn0.2 %+1,226.5 %2026Q2
Vanguard Group13.8 m2.3 bn0.0 %+0.6 %2025Q4
Geode Capital Management2.8 m1.3 bn0.1 %+11.5 %2026Q2
T. Rowe Price2.4 m1.2 bn0.1 %+289.6 %2026Q2
Bank of America2.2 m1.1 bn0.1 %+22.9 %2026Q2

Latest insider transactions

DatePersonSideAmount
07/10/2026Dyckerhoff Stefan Asale1.3 m USD
07/10/2026Dyckerhoff Stefan Asale3.1 m USD
07/10/2026Dyckerhoff Stefan Asale248,576 USD
02/09/2026Dyckerhoff Stefan Asale74,705 USD
02/09/2026Dyckerhoff Stefan Asale177,868 USD
02/09/2026Dyckerhoff Stefan Asale14,229 USD

Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 08/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
Nasdaq
IPO: 20/03/2024
ISIN code
US04626A1034
Workforce
440
full-time employees
Chief executive
Jitendra Mohan

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Astera Labs, Inc. Common Stock

What is the Astera Labs, Inc. Common Stock share price?

Latest recorded price: 190.71 USD on 06/11/2026, for a market cap of 33.1 bn USD.

What is the revenue of Astera Labs, Inc. Common Stock?

853 m USD for fiscal year 2025, with net income of 219 m USD (net margin 25.7 %).

What do analysts say about Astera Labs, Inc. Common Stock?

Out of 18 analysts: 13 buy or strong buy, 5 hold, 0 sell or strong sell. Average price target: 390.18 USD, i.e. +50.8 % from the share price.

What is the P/E ratio of Astera Labs, Inc. Common Stock?

Trailing 12-month P/E of 76.9, against 38.2 for the sector median on the same exchange (10-year median: 43.0).

Is Astera Labs, Inc. Common Stock stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US04626A1034).

How many employees does Astera Labs, Inc. Common Stock have?

440 full-time employees according to the latest published profile.

Who runs Astera Labs, Inc. Common Stock?

Jitendra Mohan is the company's chief executive.

Which large funds own Astera Labs, Inc. Common Stock?

As of 2026Q2, among the large funds tracked: Fidelity, BlackRock, State Street, Invesco, Vanguard Group.

07

Similar stocks